You are here

Malaria diagnostics in clinical trials

Malaria diagnostics in clinical trials
Sean C. Murphy, MD, PhD
Nov 2013
American Journal of Tropical Medicine and Hygiene

Malaria Diagnostics in Clinical Trials.

TitleMalaria Diagnostics in Clinical Trials.
Publication TypeJournal Article
Year of Publication2013
AuthorsMurphy, SC, Shott, JP, Parikh, S, Etter, P, Prescott, WR, V Stewart, A
JournalAm J Trop Med Hyg
Date Published2013 Sep 23

Malaria diagnostics are widely used in epidemiologic studies to investigate natural history of disease and in drug and vaccine clinical trials to exclude participants or evaluate efficacy. The Malaria Laboratory Network (MLN), managed by the Office of HIV/AIDS Network Coordination, is an international working group with mutual interests in malaria disease and diagnosis and in human immunodeficiency virus/acquired immunodeficiency syndrome clinical trials. The MLN considered and studied the wide array of available malaria diagnostic tests for their suitability for screening trial participants and/or obtaining study endpoints for malaria clinical trials, including studies of HIV/malaria co-infection and other malaria natural history studies. The MLN provides recommendations on microscopy, rapid diagnostic tests, serologic tests, and molecular assays to guide selection of the most appropriate test(s) for specific research objectives. In addition, this report provides recommendations regarding quality management to ensure reproducibility across sites in clinical trials. Performance evaluation, quality control, and external quality assessment are critical processes that must be implemented in all clinical trials using malaria tests.

Alternate JournalAm. J. Trop. Med. Hyg.